These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9524791)

  • 1. Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam.
    Bosch HC; Sigmund R; Hettich M
    Curr Med Res Opin; 1997; 14(1):29-38. PubMed ID: 9524791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. German Meloxicam Ampoule Study Group.
    Colberg K; Hettich M; Sigmund R; Degner FL
    Curr Med Res Opin; 1996; 13(7):363-77. PubMed ID: 8862936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.
    Ghozlan PR; Bernhardt M; Vélicitat P; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
    Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B
    Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the local tolerability, safety and efficacy of meloxicam and piroxicam suppositories in patients with osteoarthritis: a single-blind, randomized, multicentre study.
    Carrabba M; Paresce E; Angelini M; Galanti A; Marini MG; Cigarini P
    Curr Med Res Opin; 1995; 13(6):343-55. PubMed ID: 8829892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
    Lindén B; Distel M; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():35-8. PubMed ID: 8630634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
    Combe B; Vélicitat P; Garzón N; Bluhmki E
    Inflamm Res; 2001 Mar; 50 Suppl 1():S10-6. PubMed ID: 11339515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers.
    Patoia L; Santucci L; Furno P; Dionisi MS; Dell'Orso S; Romagnoli M; Sattarinia A; Marini MG
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():61-7. PubMed ID: 8630640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.
    Dequeker J; Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Isomäki H; Littlejohn G; Mau J; Papazoglou S
    Br J Rheumatol; 1998 Sep; 37(9):946-51. PubMed ID: 9783758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica.
    Auvinet B; Ziller R; Appelboom T; Velicitat P
    Clin Ther; 1995; 17(6):1078-98. PubMed ID: 8750399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis.
    Chang DM; Young TH; Hsu CT; Kuo SY; Hsieh TC
    Clin Rheumatol; 2001; 20(2):104-13. PubMed ID: 11346221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder.
    Vidal L; Kneer W; Baturone M; Sigmund R
    Inflamm Res; 2001 Mar; 50 Suppl 1():S24-9. PubMed ID: 11339517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First i.m., now oral. COX-2 inhibitor in acute lumbago].
    MMW Fortschr Med; 2002 Nov; 144(47):66. PubMed ID: 12532533
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-lasting beneficial effects of periradicular injection of meloxicam for treating chronic low back pain and sciatica.
    Borghi B; Aurini L; White PF; Mordenti A; Lolli F; Borghi R; Martignani M; Greggi T
    Minerva Anestesiol; 2013 Apr; 79(4):370-8. PubMed ID: 23306395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
    Singh G; Lanes S; Triadafilopoulos G
    Am J Med; 2004 Jul; 117(2):100-6. PubMed ID: 15234645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis.
    Cheng TT; Lai HM; Chiu CK; Chem YC
    Clin Ther; 2004 Mar; 26(3):399-406. PubMed ID: 15110132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and efficacy of movalis injected into trigger points in lumbago-ischialgia syndrome].
    Shirokov VA; Potaturko AV; Zakharov IaIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(9):41-4. PubMed ID: 18833170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local tissue tolerability of meloxicam, a new NSAID: indications for parenteral, dermal and mucosal administration.
    Stei P; Kruss B; Wiegleb J; Trach V
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():44-50. PubMed ID: 8630637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
    Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Dequeker J; Isomäki H; Littlejohn G; Mau J; Papazoglou S
    Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee.
    Lund B; Distel M; Bluhmki E
    Scand J Rheumatol; 1998; 27(1):32-7. PubMed ID: 9506875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.